Compounds > propylparaben
Page last updated: 2024-08-18

propylparaben and fulvestrant

propylparaben has been researched along with fulvestrant in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byford, JR; Darbre, PD; Drew, MG; Pope, GS; Sauer, MJ; Shaw, LE1
Blust, R; De Coen, W; Lenjou, M; Maras, M; Robbens, J; Van Bockstaele, D; Vanparys, C1
An, BS; Choi, KC; Jeung, EB; Nguyen, TT; Yang, H1
An, BS; Hwang, I; Jeung, EB; Jung, EM; Vo, TT; Yang, H1
Marchese, S; Silva, E1

Other Studies

5 other study(ies) available for propylparaben and fulvestrant

ArticleYear
Oestrogenic activity of parabens in MCF7 human breast cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2002, Volume: 80, Issue:1

    Topics: Animals; Binding Sites; Breast Neoplasms; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Female; Food Preservatives; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Ligands; Models, Molecular; Molecular Structure; Parabens; Protein Binding; Proteins; Receptors, Estrogen; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins

2002
Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2006, Volume: 20, Issue:7

    Topics: Alcohols; Benzhydryl Compounds; Benzo(a)pyrene; Cell Line, Tumor; Cell Nucleus Division; Cell Proliferation; DDT; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endosulfan; Estradiol; Estrogens; Flow Cytometry; Fluorocarbons; Fulvestrant; Gene Expression; Humans; Parabens; Phenols; Receptors, Estrogen; Resting Phase, Cell Cycle; Reverse Transcriptase Polymerase Chain Reaction; S Phase; Trefoil Factor-1; Tumor Suppressor Proteins

2006
Synergistic effects of parabens on the induction of calbindin-D(9k) gene expression act via a progesterone receptor-mediated pathway in GH3 cells.
    Human & experimental toxicology, 2012, Volume: 31, Issue:2

    Topics: Animals; Anti-Infective Agents; Calbindins; Cell Line; Drug Synergism; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Fulvestrant; Gene Expression; Parabens; Preservatives, Pharmaceutical; Rats; Receptors, Progesterone; RNA, Messenger; S100 Calcium Binding Protein G

2012
Calbindin-D9k as a sensitive molecular biomarker for evaluating the synergistic impact of estrogenic chemicals on GH3 rat pituitary cells.
    International journal of molecular medicine, 2012, Volume: 30, Issue:5

    Topics: Animals; Benzhydryl Compounds; Biomarkers; Calbindins; Cell Line; Drug Synergism; Endocrine Disruptors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Fulvestrant; Gene Expression; Parabens; Phenols; Pituitary Gland; Rats; Receptors, Progesterone; S100 Calcium Binding Protein G

2012
Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Benzhydryl Compounds; Benzodioxoles; Cell Culture Techniques; Cell Line; Cell Transformation, Neoplastic; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Estrogens, Non-Steroidal; Female; Fulvestrant; Gene Expression; Humans; Immunoblotting; Mammary Glands, Human; Microscopy, Confocal; Parabens; Phenols; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Trefoil Factor-1; Tumor Suppressor Proteins

2012